Introduction of Stock Compensation-Type Stock Options for Directors and Executive Officers
First written in FY2017. 19 of 20 entries say "Advanced", first in FY2018-Q2. Latest entry: FY2027-H1.
106 other companies' latest entry also says "Advanced".
- FY2027-H1AdvancedAnnual report
「The stock acquisition rights issued during the interim accounting period are as follows. Resolution date: 17 April 2026; categories and number of eligible recipients (people): 2 Company directors excluding directors serving as audit and supervisory committee members, 4 directors serving as audit and supervisory committee members, and 5 Company executive officers; number of stock acquisition rights (rights): 1,495; class, description and number of underlying shares (shares): common shares, 149,500.」
The filing describes the issuance of 1,495 share-based compensation stock options covering 149,500 shares for directors other than those serving as audit and supervisory committee members, directors serving as audit and supervisory committee members, and executive officers following the transition to a company with an audit and supervisory committee. - 2026-05-25AdvancedShare Issuance and Disposal
「The previously undecided matters among the issuance terms of the stock acquisition rights to be issued as stock-based compensation stock options to the Company’s directors (excluding directors who are Audit and Supervisory Committee members, including outside directors), directors who are Audit and Supervisory Committee members (including outside directors) and executive officers, based on the resolution of the Board of Directors meeting held on 17 April 2026, were finalized today. We hereby announce the details as follows.」
既存の株式報酬型ストック・オプションのテーマについて、2026年4月17日決議分の割当対象者、総数1,495個および目的株式149,500株など、発行内容の確定を開示しており、具体的な実行内容が前進した。 - FY2026AdvancedAnnual report
「The stock acquisition rights issued during the interim accounting period are as follows. Resolution date: 18 April 2025; categories and number of eligible recipients (people): 5 Company directors and 4 Company executive officers; number of stock acquisition rights (rights): 2,494 (Note 1); class, description and number of underlying shares (shares): common shares, 249,400 (Note 1).」
Regarding the share-based compensation stock options for directors and executive officers approved on 18 April 2025, the filing describes the issuance of 2,494 rights covering 249,400 shares. Under the compensation system following the transition to a company with an audit and supervisory committee, directors serving as audit and supervisory committee members are also eligible. - 2026-04-17AdvancedShare Issuance and Disposal
「当社は、2026年4月17日開催の当社取締役会において、会社法第236条、第238条及び第240条の規定に基づき、当社の取締役(監査等委員である取締役を除き、社外取締役を含む。)、監査等委員である取締役(社外取締役を含む。)及び執行役員に対し、株式報酬型ストック・オプションとして下記のとおり新株予約権を発行することを決議いたしましたので、お知らせいたします。」
取締役・監査等委員である取締役・執行役員を対象に、第10回新株予約権1,676個、目的株式167,600株を発行する決議を行い、既存の株式報酬型ストックオプション施策を具体的に進めている。 - FY2026-H1AdvancedAnnual report
「The stock acquisition rights issued during the interim accounting period are as follows. Resolution date: 18 April 2025; categories and number of eligible recipients (people): 5 Company directors and 4 Company executive officers; number of stock acquisition rights (rights): 2,494 (Note 1); class, description and number of underlying shares (shares): common shares, 249,400 (Note 1).」
Regarding the share-based compensation stock options for 5 directors and 4 executive officers, the filing describes the issuance of 2,494 rights covering 249,400 shares, approved on 18 April 2025. - FY2025-H1AdvancedAnnual report
「1 March 2024–31 August 2024 179 18,315 41,995 747,662 41,995 401,662 (Note) The increase resulted from the exercise of stock acquisition rights (stock options).」
Regarding the share-based compensation stock options for directors and executive officers, exercise during the interim accounting period increased the total number of issued shares by 179 thousand shares and increased stated capital and capital reserve by ¥41.995 million each. - FY2025-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Resolution date: 18 April 2024; categories and number of eligible recipients (people): 5 Company directors and 4 Company executive officers; number of stock acquisition rights (rights): 2,113; class, description and number of underlying shares (shares): common shares, 211,300.」
Regarding the share-based compensation stock options for 5 directors and 4 executive officers approved on 18 April 2024, the filing describes the issuance of 2,113 rights covering 211,300 shares. - FY2024AdvancedAnnual report
「At a meeting of the Board of Directors held on 18 April 2024, the Company resolved to issue stock options in the form of share-based compensation to its directors and executive officers.」
In addition to the existing program, the Company resolved on 18 April 2024 to issue stock options covering 211,300 shares to 5 directors and 4 executive officers. - FY2024-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Resolution date: 19 April 2023; categories and number of eligible recipients (people): 5 Company directors and 5 Company executive officers; number of stock acquisition rights (rights): 3,008; class, description and number of underlying shares (shares): common shares, 300,800.」
Regarding the share-based compensation stock options for directors and executive officers approved on 19 April 2023, the filing states that, at the time of issuance on 22 May 2023, there were 10 eligible recipients and 3,008 rights covering 300,800 shares. - FY2023AdvancedAnnual report
「At a meeting of the Board of Directors held on 19 April 2023, the Company resolved to issue stock options in the form of share-based compensation to its directors and executive officers.」
In addition to the existing share-based compensation stock options, the Company resolved on 19 April 2023 to issue options covering 300,800 shares to 5 directors and 5 executive officers. - FY2023-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Resolution date: 20 April 2022; eligible recipients: 5 Company directors and 5 Company executive officers; number of stock acquisition rights: 1,327; number of underlying shares: 132,700 shares.」
Regarding the share-based compensation stock options for directors and executive officers approved on 20 April 2022, the filing describes the issuance of 1,327 rights covering 132,700 shares to 10 eligible recipients. The total number of issued shares also increased by 8 thousand shares through exercise during the quarter. - FY2022AdvancedAnnual report
「At a meeting of the Board of Directors held on 20 April 2022, the Company resolved to issue stock options in the form of share-based compensation to its directors and executive officers.」
On 20 April 2022, the Company resolved to issue stock options in the form of share-based compensation covering 132,700 shares to 5 directors and 5 executive officers. - FY2021AdvancedAnnual report
「At a meeting of the Board of Directors held on 21 April 2021, the Company resolved to issue stock options in the form of share-based compensation to its directors and executive officers.」
On 21 April 2021, the Company resolved to issue stock options in the form of share-based compensation covering 180,200 shares to 4 directors and 6 executive officers. - FY2020AdvancedAnnual report
「Issuance of new shares (exercise of stock acquisition rights) Increase resulting from the exercise of stock options: 96,800 shares」
Regarding the stock options for directors and executive officers, 96,800 shares were exercised during the fiscal year, increasing the total number of issued shares, stated capital and capital reserve. - FY2020-Q1AdvancedAnnual report
「1 March 2019–31 May 2019 96 18,127 29,464 702,721 29,464 356,721 (Note) The increase resulted from the exercise of stock acquisition rights (stock options).」
Regarding the stock options for directors and executive officers, the filing states that exercise during the first quarter increased the total number of issued shares by 96 thousand shares and increased stated capital and the capital reserve by ¥29.464 million each. - FY2019AdvancedAnnual report
「At a meeting of the Board of Directors held on 19 April 2019, the Company resolved to issue stock options in the form of share-based compensation to its directors and executive officers.」
In addition to the existing share-based compensation stock options, the Company resolved on 19 April 2019 to issue stock acquisition rights covering 59,200 shares to 4 directors and 7 executive officers. - FY2019-Q2AdvancedAnnual report
「1 June 2018–31 August 2018 Increase/(decrease) in total number of issued shares: 17 thousand shares (Note) This was an increase resulting from the exercise of stock acquisition rights (stock options).」
Regarding the share-based compensation stock options for directors and executive officers, the total number of issued shares increased by 17 thousand shares through exercise during the second quarter accounting period. - FY2019-Q1AdvancedAnnual report
「The stock acquisition rights issued during the first quarter accounting period are as follows. Number of stock acquisition rights: 1,375 (Note 1); number of shares underlying the stock acquisition rights: 137,500 shares (Note 1); exercise period: 29 May 2018 to 28 May 2038.」
Regarding the existing share-based compensation stock option program, 1,375 stock acquisition rights covering 137,500 shares were issued during the first quarter, with an exercise period from 29 May 2018 to 28 May 2038. - FY2018-Q2AdvancedAnnual report
「Between 21 June 2017 and 31 July 2017, the total number of issued shares increased by 4,300 shares through the exercise of stock acquisition rights.」
Regarding the stock options in the form of share-based compensation introduced for directors and executive officers, the filing states that the total number of issued shares had increased by 4,300 shares through exercise as of the filing date. - FY2017First statedAnnual report
「At a meeting of the Company's Board of Directors held on 12 May 2017, the Company resolved to issue stock options in the form of share-based compensation to its directors and executive officers. Number of shares underlying the stock acquisition rights: 103,900 shares (Note 1).」
The Company resolved to issue stock options in the form of share-based compensation, covering 103,900 shares, to 2 directors and 8 executive officers. The exercise period is stated as running from 15 June 2017 to 14 June 2027.